It is estimated that 170 million people worldwide are chronically infected with hepatitis C virus (HCV) (36) . HCV infection is a leading cause of liver cirrhosis and hepatocellular carcinoma. As there is no vaccine or effective treatment available, HCV poses a significant threat to public health and there is thus an urgent need to understand the virus better and to develop vaccines and therapeutic agents (50) .
HCV, a member of the Flaviviridae, is an enveloped virus containing a single stranded, approximately 9.6-kb genomic RNA molecule of positive polarity (10) . The genome contains a single open reading frame flanked by 5Ј untranslated regions (5ЈUTRs) and 3ЈUTRs. There are at least six genotypes of HCV whose sequences differ from each other by up to 30% over the complete genome, and the genotypes are grouped into subtypes according to sequence similarities (57) . Recently, several infectious cDNA clones of HCV genome have been isolated (31, 68, 70) . The genome encodes a polypeptide of approximately 3,010 amino acids which is cotranslationally processed by the host-and virus-encoded proteases to produce at least 10 mature proteins (11, 40, 50) . In contrast to the recent progress made in understanding the genome organization of HCV, the proteolytic processing of the polyprotein and the biochemical characterization of the individual proteins, similar success in understanding the mechanisms of HCV replication has been hampered by the lack of an efficient in vivo replication system.
The HCV 5ЈUTR may play a role in viral replication and packaging. In addition, the structurally complex 5ЈUTR sequence contains an internal ribosome entry site (IRES), which drives expression of the HCV polyprotein in a cap-independent manner (22) . The HCV 3ЈUTR consists of three distinct regions-a short nonconserved variable-length sequence, a variable-length polypyrimidine tract [poly(U-UC)], and a highly conserved stretch of 98 nucleotides (nt), termed the 3ЈX, which represents the authentic 3Ј terminus of the HCV RNA genome (59) . The HCV 3ЈX contains a considerable degree of secondary structure; three stem-loop structures have been demonstrated, (6, 26, 60) , the most stable of which is formed by the 3Ј-terminal 46 nt (6, 26, 60) . Recently, the 3ЈX region and the poly(U-UC) region of the HCV 3ЈUTR have been shown to be absolutely required for in vivo infectivity (69) . In parallel with other members of the Flaviviridae family, whose 3ЈUTRs are highly conserved and contain stable secondary structures, it is possible that the 3ЈX region may serve as a cis-acting element in replication of HCV RNA. It is well established that hostencoded proteins play a role in the replication of many RNA viruses (5, 34) either by binding to the 3ЈUTR or as part of the replicase complex (17, 26, 38) . Indeed, recent evidence has demonstrated that the HCV 3ЈUTR is capable of binding polypyrimidine tract binding protein (PTB) (19, 28, 65) , hnRNP C (heterogeneous nuclear ribonucleoprotein C), (18) , La (58) , GAPDH (49) , and other cellular proteins (p87 and p130) (24) . While the roles played by PTB and La in modulation of IRESmediated translation of HCV are being clarified (1, 25, 27, 28) , the significance of the interaction between PTB, La, hnRNP C, GAPDH, and other unidentified 3ЈUTR binding proteins in HCV replication, or other aspects of HCV biology, is not yet understood.
The development of the Saccharomyces cerevisiae three-hybrid system allows the analysis and identification of RNAbinding proteins in vivo (56) . Using this system, we identify human ribosomal proteins (RPs) L22, S3, L3, and mL3, the mitochondrial homologue of L3, as novel HCV 3ЈX RNAbinding proteins. These proteins may be involved in replication, translation, and/or packaging of HCV. We characterized the binding between these proteins and 3ЈX-derived sequences by three-hybrid mating analysis. The 3ЈX-L22 interaction was selected for further characterisation both in cell culture and in vitro. Translational analysis in cell culture using mono-and bicistronic reporter constructs showed that the 3ЈX-L22 interaction may modulate IRES-mediated translation of the HCV open reading frame.
MATERIALS AND METHODS
Plasmid constructs expressing HCV 3UTR. HCV 3ЈUTR sequences were amplified by PCR using an infectious HCV cDNA clone pCV-H77c (68) (kindly supplied by J. Bukh) as a template. Primers used for amplification of full-length (FL) 3ЈUTR were Upper, 5Ј tctagaactagtggatccCCCGGGaggttggggtaaacactccg gcctct 3Ј, and Lower, 5Ј tctagaactagtggatccCCCGGGacatgatctgcagagaggccagtat 3Ј; primers used for amplification of the 3ЈX were Upper, 5Ј tctagaactagtggatcc CCCGGGaatggtggctcctcttagccc 3Ј, and Lower, 5Ј tctagaactagtggatccCCCGGG acatgatctgcagagaggccagtat 3Ј (where the Sma I site used for cloning is in uppercase and H77c DNA sequences are in boldface type). The resulting PCR products (268-bp FL 3ЈUTR; 148bp 3ЈX) were inserted by standard techniques into pBluescript SK vector (Stratagene) or the hybrid RNA expressing plasmids pIIIA/MS2-1 and pIIIA/MS2-2, which both carry the ADE2 and URA3 genes (56) . Since it has been previously reported that the relative order of the RNA sequence of interest and the MS2 sites can affect signal strength in the threehybrid assay (56), we cloned the 3ЈX sense (ϩ) sequence into both pIIIA/MS2-1 and pIIIA/MS2-2 to generate 3ЈX-MS2 and MS2-3ЈX RNAs, respectively, in vivo. These constructs have been designated p3ЈX (ϩ)-MS2 and pMS2-3ЈX (ϩ), respectively. Additionally we fused the 3ЈX antisense (Ϫ) sequence to the 5Ј end of the MS2 sequence into pIIIA/MS2-2 to generate plasmid p3ЈX (Ϫ)-MS2. The FL 3ЈUTR (sense) sequence was cloned into pIIIA/MS2-1 to generate pMS2-FL3ЈUTR. Plasmids encoding 3ЈX/MS2 mutants were prepared using standard PCR strategy, and the mutant 3ЈX sequences were cloned into pIIIA/MS2-2. The three mutants used in this study are designated p3ЈX SL1 (ϩ)-MS2, p3ЈX SL2 (Ϫ)-MS2, and p3ЈX 23L1S (Ϫ)-MS2. p3ЈX SL1 (ϩ)-MS2 corresponds to a 3ЈX sequence where CUCUGCAGA (nt 84 to 92) within the stem I has been replaced with ACAGCGCU. p3ЈX SL2 (Ϫ)-MS2 corresponds to a stem II mutation where the sequence UCACGGCU (nt 23 to 30) has been replaced with GCUAGCUC, in the antisense orientation. p3ЈX 23 L1S (Ϫ)-MS2 corresponds to a triple antisense mutant where the sequences GGCTG (stem III, nt 4 to 8), UCACGGCU (stem II, nt 23 to 30), and GCUCCUCUGCAGA (stem I, nt 80 to 92) have been replaced with CCGAG, GCUAGCUC, and GCUCCUGCAU CGG (stems III, II, and I, respectively). The sequence and orientation of all the constructs described in this study were determined using an ABI Prism 377 DNA sequencer (Perkin-Elmer).
Expression of L22 and La. FL L22 (clone 66) was excised with appropriate restriction enzymes from the activation domain (AD) vector pGADGH and subcloned into the bacterial or mammalian expression vector pGEX-6P-3 (Pharmacia) or pcDNA3.1/Zeo(ϩ) (Invitrogen), respectively. A DNA fragment encoding the FL La protein (a kind gift from Ger Pruijn) was cloned into pcDNA3.1/Zeo(ϩ) to yield pcDNA-La. The glutathione S-transferase (GST)-L22 fusion protein was expressed in Escherichia coli BL21 cells following induction with IPTG (isopropyl-␤-D-thiogalactopyranoside) (1 mM final), and purified by binding to glutathione agarose beads (Sigma). For in vitro RNA-binding studies, GST-L22 was treated with PreScission protease (Pharmacia) to remove the GST part of the fusion protein before use. For RNA gel mobility shift assays (RNA GMSA), the GST-L22 protein was purified further by gel filtration on a Superdex-75 column (Pharmacia) using fast-performance liquid chromatography equipment (Pharmacia). Proteins were eluted in RNA-binding buffer supplemented with 10% glycerol, and fractions were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting.
Construction of core-CAT reporter plasmids. Using standard techniques, one bicistronic and two monocistronic constructs carrying sequences encoding HCV core and chloramphenicol acetyltransferase (CAT) were generated. The monocistronic constructs designated pCV-5CC3 and pCV-48L were generated in the pCV vector described by Yanagi et al. (68) ; they contain the sequences encoding the entire 5ЈUTR, the FL HCV core protein (nt 1 to 924 of HCV genome, [68] ) fused in frame to the CAT gene, followed by a stop codon and the FL 3ЈUTR (nt 9378 to 9599 [68] ). pCV-48L also contains the delta ribozyme sequence cloned 3Ј of the HCV 3ЈUTR, which is designed to self-cleave and generate an authentic HCV 3Ј terminus. As in pCV-H77c (68), the T7 promoter in both pCV-5CC3 and pCV-48L is expected to generate transcripts with the authentic 5Ј end of HCV 5ЈUTR. The translation of these RNA transcripts should be mediated by HCV IRES and is expected to produce a core-CAT fusion protein. The core domain from this fusion protein is expected to be cotranslationally cleaved on account of the presence of the signal peptidase cleavage sites in these constructs. The bicistronic construct, pRL-5CC3 contains the Renilla luciferase gene cloned under the control of the T7 promoter in the vector pTZ-18i (Pharmacia). Following the luciferase sequence are the 5ЈUTR-core-CAT-3ЈUTR sequences as described above. The primary translation products from pRL-5CC3 are Renilla luciferase and the core-CAT fusion protein. These constructs are schematically represented below (see Fig. 4A ).
Northern blot analysis. The hybrid RNA-expressing plasmids were used to transform yeast L40coat strain (which contains a gene expressing the LexA-MS2 coat protein fusion stably integrated into the yeast chromosome), and transformants were selected and maintained on plates lacking uracil. To confirm that the appropriate hybrid RNA molecules were produced in vivo, total RNA from each yeast strain was analyzed by Northern blotting, using an MS2 DNA probe or strand-specific 3ЈX riboprobes. Briefly, total RNA from the appropriate yeast strain was fractionated on denaturing formaldehyde agarose gels, capillary blotted onto nylon membrane, and UV cross-linked. For probe preparation, the MS2-encoding DNA fragment was excised from pIIIA/MS2-1, gel purified, and radiolabeled by random priming (Prime-It II kit; Stratagene) using [␣-
32 P]dCTP. High-stringency Northern analysis was performed by hybridizing blots at 65°C for 1 h using Rapid Hyb buffer (Amersham) and washing three times at 65°C for 30 min in 0.1ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.1% SDS. The resulting blots were exposed to X-ray film for 3 days. Similar blots were prepared and hybridized under the same conditions of stringency using strandspecific riboprobes, i.e. 3ЈX sense and 3ЈX antisense to check for in vivo production of the appropriate HCV RNA.
Three-hybrid selection and screening. Selection and screening were essentially performed as previously described (56, 72) with some minor modifications. A derivative of yeast strain L40coat, containing p3ЈX-MS2, was transformed with DNA from a HeLa, HeLa S3, or human liver cDNA library constructed in activation domain plasmids pACTII, pGADGH, and pACT, respectively (Clontech). Yeast transformants were plated on synthetic medium lacking leucine and histidine and supplemented with 2 to 5 mM 3-aminotriazole to select for higher activation of HIS3. RNA-independent positives were initially eliminated through red or white color selection, followed by 0.1% 5-fluoroorotic acid selection as described previously (71) . To confirm that the RNA-dependent clones were true positives, hybrid RNA-expressing plasmids were introduced by mating with each of four derivatives of the yeast strain R40coat (opposite mating type to L40coat) carrying pMS2-3ЈX (ϩ), p3ЈX (ϩ)-MS2, p3ЈX (Ϫ)-MS2, or pMS2-FL 3ЈUTR (ϩ). The mating mixtures were incubated overnight and plated on medium lacking uracil and Leu. After 3 days of growth, filters were lifted from each of the mating plates (lacking uracil and Leu) and the counterpart cured plates (without Leu but containing 0.1% 5Ј-fluoruorotic acid) and were tested for ␤-galactosidase (␤-Gal) activity. For positive RNA-dependent clones, the mating should reintroduce the RNA-expressing plasmid and restore the previously observed positive phenotype in the ␤-Gal assay (blue). In contrast, filters lifted from the counterpart cured plate, where the yeast does not contain the RNA-expressing plasmid, should remain negative in the ␤-Gal assay (no blue color). DNA isolated from RNA-dependent positive yeast clones was used to transform E. coli TG1 cells. Plasmid DNA was sequenced using AD forward and reverse primers. For verification and determination of relative affinity of RNA-protein interactions a liquid o-nitrophenyl-␤-D-galactopyranoside (ONPG) assay for ␤-Gal activity was used.
SDS-PAGE and immunoblotting. Protein samples were mixed with SDS-PAGE denaturing buffer (50 mM Tris-HCl [pH 6.7] 2% SDS, 5% ␤-2-mercaptoethanol, 10% glycerol, 0.001% bromophenol blue) and fractionated on SDS-12.5% polyacrylamide gels. For Western blotting, proteins were electrophoretically transferred to Hybond ECL membranes (Amersham) as previously described by Towbin et al. (64) . Membranes were incubated with an appropriately diluted rabbit anti-L22 polyclonal antiserum (gift from Joan Steitz) or an anti-GST monoclonal antibody. The immunoreactive proteins were detected using protein A-or goat anti-mouse immunoglobulin G-horseradish peroxidase conjugate and enhanced chemiluminescence reagents (Amersham).
Riboprobe production. Plasmids carrying 3ЈUTR, 3ЈX, and Epstein-Barr virus (EBV)-encoded RNA 1 (EBER1) sequences (kindly provided by M. Clemens [13] ) were linearized by cleavage with an appropriate restriction enzyme immediately downstream from the respective inserts. The linearized DNA constructs were transcribed in vitro using T7 RNA polymerase (Promega) and [␣-
32 P]CTP (NEN) according to the manufacturer's instructions. The resulting high-activity riboprobes were subjected to nondenaturing PAGE, visualized by autoradiography, excised, and eluted from the gel by incubation at 37°C in RNA elution buffer (0.5 M ammonium acetate, 0.1% SDS, 1 mM EDTA). The probes were then precipitated with ethanol and resuspended in nuclease-free water.
RNA GMSA. Various amounts of protein were mixed with 20 g of yeast tRNA (Sigma) and 40 U of RNasin (Promega) in a final volume of 25 l of RNA-binding buffer [10 mM Tris-HCl (pH 7.2), 100 mM KC1, 3 mM magnesium acetate, 5% glycerol, 1 mM EDTA]. In competition assays, a fixed amount of protein in RNA-binding buffer was preincubated with different amounts of unlabeled competitor RNA. Following incubation at 30°C for 10 min, 32 P-labeled RNA (50,000 cpm) was added and the reaction mixture was incubated for a further 20 min. After adding the tracking dye sample (1ϫ RNA-binding buffer, 0.05% bromophenol blue, and 0.05% xylene-cyanol), the reaction mixtures were fractionated on a preelectrophoresed (200 V for 30 min) nondenaturing 6% polyacrylamide gel in 1ϫ TBE (0.089 M Tris-borate, 0.089 M boric acid, 0.002 M EDTA). Electrophoresis was carried out at 200 V for 2 to 3 h. The gel was dried, exposed overnight to a phosphor screen, and visualized with a Bio-Rad Personal FX phosphorimager.
UV cross-linking analysis. For UV cross-linking of RNA to proteins, various amounts of protein were mixed with 20 g of yeast tRNA (Sigma) and 40 U of RNasin (Promega) in a final 25 l volume of RNA-binding buffer. In competition assays, different amounts of unlabeled RNA were preincubated with a fixed amount of protein in the binding buffer. Following incubation at 30°C for 10 min, 32 P-labeled RNA (50,000 cpm) was added and the reaction mixture was incubated at 30°C for a further 20 min. The reaction mixtures were then placed on ice and irradiated with UV light for 30 min at a wavelength of 254 nm (Stratalinker; Stratagene). After irradiation, 5 l of RNase cocktail (containing RNase A and RNase T 1 ) (Ambion) was added to each reaction mixture followed by incubation at 37°C for 15 min. For fractionation of samples by SDS-PAGE, 15 l of 3ϫ sample buffer was added to each reaction mixture, and the samples were boiled for 3 min, chilled on ice, and electrophoresed on a 12.5% polyacrylamide gel containing 0.1% SDS. The gels were dried, exposed to phosphor screens, and visualized with a Bio-Rad Personal FX phosphorimager.
Transfection of cultured cells. HuH7 cells (45) were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 2% glutamine, 1% nonessential amino acids, penicillin (100 U/ml), and streptomycin (100 U/ml). Subconfluent monolayers of cells in six-well (35-mm-diameter well) plates were infected with vTF7-3, a recombinant vaccinia virus expressing T7 RNA polymerase (16) , at a multiplicity of infection of 5, in 100 l of medium for 1 h at 37°C. The cells were then transfected with plasmid DNA using liposomes as described previously (55) . Following incubation at 37°C for 16 h, the cells were harvested and the cell lysates assayed for luciferase and CAT activity, as described below.
CAT and Renilla luciferase assays. Transfected cells were washed with and harvested in 100 l of 0.25 M Tris-HC1 (pH 7.4). Cell lysates were prepared by freeze-thaw followed by sonication and centrifugation at 13,000 rpm for 5 min in a Sanyo MSE Micro Centaur. The supernatant was removed, and total protein concentration was determined by the Bradford assay (8) . CAT assays were carried out using 10 g of protein and [
14 C]chloramphenicol (0.025 mCi/ml; NEN) essentially as described by Gorman et al. (20) . The radioactivity in the substrate and the acetylated products was visualized with a Bio-Rad Personal FX phosphorimager and quantitated by using Quantity One volume analysis software (Bio-Rad). Approximately 10-g protein samples were assayed for Renilla luciferase activity using a dual luciferase reporter assay system (Promega) according to the manufacturer's instructions. Luciferase activities were measured using a Biotrace M3 benchtop luminometer.
RNA secondary structure analysis. RNA secondary structures were predicted using GCG Mfold which uses the most recent energy minimization method of Jaeger et al. (30) . The structures were displayed using GCG Plotfold and Squiggles output. The associated free energy of each structure is listed in kilocalories per mole. Plots were scanned using an AGFA Studioscan II flatbed scanner and manipulated in Abode Photoshop, version 4.01.
RESULTS
In vivo expression of hybrid RNAs. We generated plasmids expressing hybrid RNAs in which bacteriophage MS2 coat protein binding sites are fused to HCV 3ЈX or FL 3ЈUTR sequences. The 3ЈX sequence was inserted in either sense or antisense orientation, and the relative order of the MS2 and HCV sequences was varied. To verify that the appropriate RNA was transcribed by RNA polymerase III in the yeast strains expressing hybrid RNA sequences, Northern blotting of total RNA was performed. Results using the MS2-specific probe showed that the hybrid RNAs carrying 3ЈX sequences [MS2-3ЈX (ϩ), 3ЈX (Ϫ)-MS2, and 3ЈX (ϩ)-MS2] all contain MS2 sequence, as transcripts of ϳ164 nt (Fig. 1A) . The hybrid RNA carrying the FL 3ЈUTR sequence [MS2-FL 3ЈUTR(ϩ)] also contained MS2 sequence, but the transcript size (ϳ134 nt) was smaller (Fig. 1A) . Northern blot analysis using 3ЈX (sense) and 3ЈX (antisense) strand-specific riboprobes showed as expected that the yeast strain designated 3ЈX (Ϫ)-MS2 expressed the antisense 3ЈX sequence (Fig. 1B) , and those designated MS2-3ЈX (ϩ) and 3ЈX (ϩ)-MS2 expressed the sense 3ЈX sequence (Fig. 1C) . The sizes of the 3ЈX-MS2 hybrid RNAs are consistent with those obtained from the MS2 Northern blot (Fig. 1A) . In contrast, the yeast strain designated MS2-FL 3ЈUTR (sense) expressed a shorter RNA transcript (ϳ134 nt), which contained the MS2 sequence (Fig. 1A) but no HCV 3ЈX sequence (Fig. 1C) . The smaller size of the FL 3ЈUTR transcripts produced in vivo is probably a result of termination of Yeast three-hybrid screen. Having established that the 3ЈX (ϩ)-MS2 hybrid RNA is correctly expressed in yeast (Fig. 1) , we used this RNA in a three-hybrid assay to screen human liver and HeLa cell activation domain cDNA libraries prepared in GAL4 AD vectors (Clontech). Between 1.5 ϫ 10 6 and 10 7 independent clones were screened in total. The screening on 3-aminotriazole plates lacking Leu and His yielded approximately 3,000 white colonies, which were subjected to further rounds of selection to eliminate false-positive clones.
The criteria imposed to identify genuine positives were that (i) they had to be RNA-dependent positives as verified by the loss of ␤-Gal activity in the absence of the RNA-expressing plasmid and (ii) these RNA-dependent positives had to be RNA-specific as shown by the restoration of ␤-Gal activity following mating with yeast strains expressing 3ЈX (ϩ)-MS2 or MS2-3ЈX (ϩ), but not MS2-FL 3ЈUTR (ϩ), which does not express any 3ЈX sequence (Fig. 1) . The cDNA inserts of library-derived plasmids from RNA-dependent, RNA-specific positive colonies were sequenced. A DNA database search identified these as independent cDNA clones encoding either human RP L22, S3, or L3 (each identified several times) or mL3, the mitochondrial homologue of L3 (identified once).
Characterization of 3X-RP interactions. To further characterize the interaction between the RPs and 3ЈX sequences, we selected clones of each protein containing minimum 5ЈUTR sequence and maximum coding sequences. For L22, we used clone 66, which carried the FL L22 cDNA with minimal 5Ј noncoding sequence (a GCC triplet) between the EcoRI linker used to clone the library into the GAL4 AD and the initiating methionine codon. L40coat yeast transformants carrying constructs expressing AD-RP cDNAs fusion proteins were mated with R40coat transformants expressing wild-type or mutant 3ЈX/MS2 hybrid RNA sequences. The in vivo activity of each RNA-protein interaction (expressed as units of ␤-Gal activity) was determined in triplicate using quantitative ONPG assay (Table 1) . Compared to the well-characterized iron-regulatory protein-iron-regulatory element (IRP-IRE) interaction (4, 21) , the activity of the 3ЈX (ϩ) and L22 or mRPL3 interaction was higher ( Table 1 ). The binding of S3 and L3 to 3ЈX (ϩ) produced lower ␤-Gal activity than that between IRP and IRE; S3 was approximately half as much, whereas L3 was approximately 1/10 as much. The use of sense and antisense 3ЈX RNA revealed that each protein had different sense specificity for the 3ЈX region. The binding of L22 to the 3ЈX (Ϫ) RNA produced nearly twofold more activity than binding to the 3ЈX (ϩ) RNA. In contrast, S3 and L3 produced with lower activity, whereas mRPL3 failed to bind 3ЈX (Ϫ) ( Table 1 ).
The differences in ␤-Gal activities associated with each of the proteins and three RNA mutants revealed that the proteins are likely binding to different areas within the 3ЈX region. L22 did not bind to any of the three mutants, whereas mRPL3 was capable of binding to the stem-loop II mutant and the triple stem-loop mutant, although the ␤-Gal activity associated with binding to these two mutants was approximately 30% of the value associated with binding to 3ЈX (ϩ). S3 and L3 were both able to bind to the stem-loop I mutant, although with reduced ␤-Gal activity (64 and 79.4%, respectively), whereas the binding to both the stem-loop II and the triple mutant was greatly reduced in each case.
Of the four RPs identified in the library screening procedure, mRPL3 and L22 exhibited the strongest activity with the 3ЈX sequence. Although mRPL3 expression has been shown to be upregulated in hepatocellular carcinoma (47) and may therefore be of interest with regard to HCV infection, little is known about the biochemical properties of this protein. In contrast, given the high number of independent L22 cDNA clones isolated in the screening procedure and the fact that L22 is well characterized (15, 17, 35, 66) and is known to bind to EBERs (63), we selected the interaction between 3ЈX and L22 for further investigation.
HCV 3X interacts with human RPL22 in vitro. In order to confirm the binding of L22 to the 3ЈX sequence, we expressed FL L22 in E. coli as a GST fusion protein. As shown in Fig. 2A , purified GST-L22 fusion protein and L22 cleaved from the GST moiety both appeared as major bands with apparent molecular masses of 42 and 15 kDa, respectively, on SDS-PAGE. Western blot analysis using a rabbit anti-L22 polyclonal antibody and an anti-GST monoclonal antibody confirmed that the 42-and 15-kDa proteins are GST-L22 and L22, respectively ( Fig. 2B and C) . These protein preparations were further purified by gel filtration chromatography for use in in vitro RNA- binding assays. To confirm that the purified GST-L22 and L22 proteins interacted with the 3ЈX sequence, we performed RNA GMSA and UV cross-linking experiments using the 32 P-labeled 3ЈX riboprobe. The results showed that two RNA-protein complexes of lower mobility were formed in which the intensity of these complexes was proportional to the GST-L22 protein concentration (Fig. 2D, lanes 2 to 7) . Additionally, these RNA-protein complexes were subject to competition with increasing amounts of unlabeled competitor 3ЈX RNA, indicating that the interaction between L22 and 3ЈX RNA is specific (Fig. 2D, lanes 9 to 13) . No RNA-protein complexes were formed when GST-L22 was replaced with GST alone or GST fused to HBV preS1 (GST-preS1) protein in the assay (data not shown).
The interaction between L22 protein and 3ЈX was further confirmed in UV cross-linking experiments using purified GST-L22 or L22 alone and a 32 P-labeled 3ЈX riboprobe. As shown in Fig. 3A , the 42-kDa GST-L22 cross-linked to the 3ЈX RNA in a dose-dependent manner. This binding was subject to competition by cold, unlabeled 3ЈX RNA, indicating that the L22-3ЈX interaction is specific (Fig. 3B) . Similarly, the 15-kDa L22 bound the radiolabeled 3ЈX riboprobe, which could be competed for by cold probe (data not shown). To further confirm that the 3ЈX did not bind to protein in a nonspecific manner, we also performed UV cross-linking assays using GST protein alone. As shown in Fig. 3C and D the 3ЈX probe interacted with GST-L22 and L22, but not with GST.
Since L22 was initially shown to bind EBER1, a small RNA molecule associated with latent EBV infection (63), we performed UV cross-linking experiments using the GST-L22, L22, and GST protein preparations together with an EBER1 riboprobe. As with HCV 3ЈX, the 32 P-labeled EBER1 RNA inter- acted with the 42-kDa GST-L22 protein (Fig. 3E ) and the 15-kDa L22 protein (Fig. 3F ), but not with GST protein alone. The EBER1-L22 interaction was also verified in GMSA by an electrophoretic shift of the EBER1 probe (data not shown), and its specificity was confirmed in competition assays using unlabeled EBER1 RNA (data not shown).
Since our three-hybrid mating assays had demonstrated that L22 could interact with the 3ЈX antisense RNA, we performed UV cross-linking assays using GST-L22 or L22 protein and 3ЈX (antisense) riboprobe derived from HCV strain H77c cDNA. Similar to our results obtained with 3ЈX (sense) and EBER1, we observed the formation of RNA-protein complexes of ϳ42 and ϳ15 kDa between 3ЈX (antisense) and GST-L22 and L22, respectively; no complex formation was observed with GST alone (Fig. 3G and H) . Functional significance of L22-3X interaction. To establish the functional role of the 3ЈX-L22 interaction during viral infection we tested the possible effect of L22 on IRES-mediated translation of a panel of monocistronic and bicistronic constructs (Fig. 4A) , both in vitro and in cell culture, as described previously (27, 28) . Since La protein has also been shown to bind the HCV 5ЈUTR and 3ЈUTR (2, 58), we also tested the effect of this protein in our assays. HuH-7 cells were infected with a vaccinia virus expressing T7 RNA polymerase (vTF7.3), followed by transfection either of a plasmid vector expressing a reporter cDNA alone or cotransfection of a reporter cDNA with an L22 or La mammalian expression construct. Total cellular lysates were prepared, and equal amounts (in terms of total protein) of each extract were assayed for luciferase and CAT activity as described in Materials and Methods. The CAT activities were quantitated by directly comparing the amount of diacetylated chloramphenicol produced by extracts of cells cotransfected with each of the two monocistronic constructs pCV-48L or pCV-5CC3 and either pcDNA3.1/Zeo(ϩ) alone, pcDNA-L22, or pcDNA-La (Fig.  4B) . Since the amount of the diacetylated product reflects the CAT activity under the control of the HCV IRES, it should indicate any effect of the L22 or La proteins in trans. Results from three separate experiments revealed an effect of L22 and La on apparent IRES activity. For pCV-48L, L22 and La increased IRES activity to 2.1-and 3.8-fold, respectively. A slightly smaller effect was seen with pCV-5CC3, for which L22 and La increased apparent IRES activity by 1.8-and 3.4-fold, respectively. This enhancement of apparent IRES activity was consistent with results obtained from five separate experiments using the bicistronic construct pRL-5CC3 (Fig. 4B ). L22 and La increased IRES activity to 2.3-and 2.2-fold, respectively.
We also tested the effect of L22 in reticulocyte lysates programmed with RNA transcribed from the linearized monocistronic construct pCV-5CC3. Consistent with the twofold increase in CAT activity seen with L22 in cell culture, we observed a twofold increase in CAT activity in reactions supplemented with either recombinant GST-L22 or His-L22 (data not shown) but not in reactions supplemented with GST alone (data not shown).
DISCUSSION
Using an in vivo library screening procedure we identified four human RPs (L22, L3, S3, and mL3) that can bind the HCV 3ЈX region. We further characterized the interaction between 3ЈX and L22 in vitro, demonstrating that RNA-protein complex formation is specific, concentration dependent, and subject to competition. Fulfillment of these three criteria suggests the validity of this RNA-protein interaction. L22 also stimulated HCV IRES-mediated expression of a bicistronic construct twofold in a human liver cell line.
Human L22 (35) was originally identified as a 15-kDa protein capable of binding two small, highly abundant EBERs (EBER1 and -2) in cells latently infected with EBV (63) . L22 also binds HVP1, a small virally encoded RNA analogous to EBER1, detectable in baboon cells infected with herpesvirus papio (63) . L22 is found in the 60S ribosomal subunit, and is located in both the cytoplasm and nucleolus. The cellular ligand of L22 is predicted to be a region of human 28S rRNA corresponding to the stem-loop between nt 302 and 317 (15) .
Both EBERs are predicted to have stable secondary structures. L22 has been shown to bind EBER1 mainly in stem-loop III and less strongly in stem-loop IV (Fig. 5A) (62) . Mutational analysis of stem-loop III has shown that L22 recognizes the majority of the nucleotides in this hairpin, interacting with both single-stranded and double-stranded regions in a sequence-specific manner (62) . L22 binding to EBER1 stemloop 3 has been suggested to be a critical aspect of EBER1 and HVP1 function, since this structure represents the region most highly conserved between EBER1 and HVP1 (62) . The L22 binding site in EBER1 stem-loop III is largely palindromic (62) . Interestingly, the double-stranded region of stem-loop I (46 nt) in the 3ЈX region also contains a sequence (CUGCAGA; nt 59 to 65 and 86 to 92 [ Fig. 5B] ) which is directly repeated on each side of the stem to form a palindromic region, similar to that observed for EBER1 (62) . Our data show that L22 binding to a 3ЈX stemloop I mutant, that does not contain a palindrome sequence is abrogated, implicating this region in binding.
The generalized RNA motif that mediates the interaction of RNA with L22, as determined by systematic evolution of ligands by exponential enrichment (SELEX) (15) , consists of a stem with a GC base pair at the apical end and a loop of six to nine bases, the most 3Ј of which is a U residue. An exact mirror image of this motif is present in stem-loop I of the 3ЈX sequence, further suggesting that this region is likely involved in (Fig. 3) . This observation is consistent with evidence showing that EBER1 has two L22 binding sites and is capable of binding two L22 molecules simultaneously (15) . Our data also demonstrate that a 3ЈX (antisense) riboprobe can bind L22 in UV cross-linking analysis. Secondary structure analysis of the antisense strand shows that the 3Ј-terminal 46 nt of the 3ЈX (domain I), which contains the palindromic region, is preserved in the two most stable predicted structures ( Fig.  5C and D, nt 1 to 45), again suggesting that this region may be involved in binding to L22. Alternatively, strand-specific regions may be involved in 3ЈX binding to L22, as revealed by a comparison between EBER1 and H77c 3ЈUTR sequences, which showed distinct regions of similarity between the sense strand and EBER1, and the antisense strand and EBER1. Within the 3ЈX sense strand, nt 19 to 25 (GCCCUAG) are identical to nt 13 to 19 within EBER1, a region which lies in the first stem-loop structure (domain I, Fig. 5A ). This region of EBER1 has not been shown to be involved in binding to L22 previously (61) . In contrast, nt 92 to 98 (AGCCACC) within the antisense strand of 3ЈX are identical to a region encompassing nt 53 to 59 within EBER1, which lies in domains II and III (Fig. 5A ), a region which has previously been shown to be involved in binding to L22 (61) . Conceivably, these distinct regions of identity with EBER1 may be involved in binding of L22 to both 3ЈX sense and antisense strands. The requirement for multiple sequences or stem-loops within the 3ЈX region for binding to L22, particularly if more than one L22 molecule can bind, would be consistent with the EBER1-L22 interaction, which involves at least two stem-loop structures within the RNA molecule (61) . Further mutational analysis is necessary to establish the exact regions within 3ЈX that are involved in binding to L22. Analysis of the potential roles played by host cellular factors during HCV infection is difficult to establish since there is no efficient HCV propagation system and assays based upon HCV replication and packaging have not yet been developed. It is well-established that RNA viruses frequently subvert cellular proteins for replication and transcription of viral RNAs, and many of these factors are involved in host translation or RNA processing. To date, the only assays available to test the functional significance of HCV RNA-binding proteins are based upon translation, either in vitro or in cell culture, using monocistronic and bicistronic reporter constructs (14, 23, 28) . The reporter constructs we used in our experiments contained the entire 5ЈUTR and the FL HCV core protein (191 amino acids). The 5Ј end of core sequence is part of the IRES structure of HCV RNA (52, 53) and the 3Ј end of the core coding sequence contains a PTB binding site, which together with the 3ЈUTR can modulate translation from the 5Ј end (27) . We initially tested the effect of host cellular factors in cell culture, since cell-free experiments using programmed reticulocyte lysates and recombinant protein are not always conclusive. Reticulocyte lysates translate RNAs very efficiently, and the effect of addition of exogenous protein on translation can be difficult to detect. The supplementation of recombinant protein produced in E. coli to reticulocyte lysates can be misleading if no apparent effect on translation is observed. This may be due to a lack of posttranslational modifications such as arginine methylation, or the presence of extra tag sequences which can alter the RNA-binding properties of a protein. Also, successful immunodepletion experiments, which can equivocally demonstrate the functional significance of a putative trans-acting factor, were complicated by the fact that L22 is a component of the ribosome. It would be difficult to physically deplete L22 from the extract, and depletion might have resulted in a decreased translational efficiency simply because the structure and function of the ribosome had been impaired. Additionally, depletion of the putative trans-acting factor often results in the removal of associated proteins whose loss may be responsible for the observed effect on translation (29) . For translational analysis of L22 we used HuH-7 cells, which have recently been shown to support replication of a subgenomic HCV RNA (41) . Experiments using three core-CAT reporter constructs (Fig.  4A) revealed that L22 and La, when supplied in trans, correlated with an upregulation of CAT activity by a factor of ϳ2 (L22) or Ͼ2 (La) when compared to cells transfected with the same reporter construct and an empty vector. This upregulation of apparent IRES activity by L22 was confirmed in vitro, as a twofold increase was obtained using recombinant GST-L22 and histidine-tagged L22 (data not shown).
With regard to the interaction between L22 and the 3ЈX region, a number of roles for L22 are possible. L22 may be a factor directly involved in translation of HCV RNA, perhaps playing a role similar to the La protein which has been shown to bind both to the 5ЈUTR in the context of the initiating AUG codon (2) and also to the 3ЈUTR (58). L22 and La are both capable of binding EBERs in vivo, and both proteins are associated with ribosomes in the cytoplasm. La localizes with a subset of small ribosomal subunits, possibly by direct association with 18S rRNA. This is consistent with the putative role of this protein in translation regulation (48) . Alternatively, L22 may be playing a regulatory role in translation (35) , similar to that recently proposed for PTB (p57, hnRNP I), in which multiple binding sites within the HCV genome affect the efficiency of translation in vivo or ensure that only an FL genomic RNA is translated (27) . Another interpretation of the apparent increase in HCV IRES activity in the presence of L22 and La could be an effect on RNA stability. If the half-life of the transcripts in vivo are increased in the presence of L22 or La, due to a stabilization by the bound protein within the 3ЈX region, greater amounts of the core-CAT fusion protein could be produced. An RNA stability effect of L22 would be consistent with the previously described role for La in stabilization of histone mRNAs (43) and for RPL3 in stabilization of human immunodeficiency virus long terminal repeat-directed RNA (51) . However, our preliminary Northern blot analysis show that cells transfected with the reporter constructs used in this study produce, as expected, RNA transcripts of appropriate length both in the presence and absence of exogenously expressed L22 or La (data not shown). Furthermore, there was no evidence of instability of such transcripts in these cells, making it difficult to ascertain whether L22 (or La) plays a role in RNA stability.
Although L22 may have a role to play in translation of HCV, translation factors are not usually involved in regulation of the translation of RNA viruses since they do not bind to viral sequences directly involved in translation (34) . More commonly, translation factors interact with either the RNA-depen-dent RNA polymerase (RdRp) or cis-acting replication signals, suggesting their roles in viral RNA synthesis. It is well-established that purified viral RNA polymerases lacking cellular factors are usually enzymatically inactive or lack template specificity (34) . Cellular proteins have been shown to restore such inactivity or to provide template-specificity to the RdRp (reviewed by Lai [34] ). The proteins can serve either directly as part of the replicase complex (7) or by association with RNA (3), or both (34) , to direct the replicase complex to the template (3). Conceivably, any of the four RPs identified in this study as 3ЈX binding proteins could serve to direct the HCV replicase complex to the template or to govern template specificity of the RdRp.
Another intriguing possibility is that any of the 3ЈX-RP interactions may represent a mechanism by which HCV evades the effects of the interferon-inducible enzymes protein kinase R and 2Ј-5Ј oligoadenylate synthetases. These enzymes are activated by double-stranded RNA and act in pathways that can inhibit host protein synthesis, thereby modulating cell growth and apoptosis (12, 42) . Since both protein kinase R and 2Ј-5Ј oligoadenylate synthetases play fundamental roles in the interferon-induced antiviral response, viruses have evolved multiple mechanisms to evade the shutoff of protein synthesis (reviewed by Mathews [42] ). Recent evidence has demonstrated that individual RPs may also play a role in the prevention of shutoff of host protein synthesis (9, 33, 44, 54) . It is clear that ribosome-associated proteins are involved in signaling pathways that affect rates of cellular protein synthesis and can thus govern processes such as regulation of cell proliferation and the cellular stress response. Although there is no direct evidence for the involvement of L22 in signaling pathways that affect cellular growth rate, the protein has recently emerged as a cellular factor that can bind both viral RNA (EBERs) (63) and viral proteins (herpes simplex virus type 1 ICP4) (39) , although the significance of the interaction in each case is still not clear.
The diverse array of extraribosomal functions of individual RPs has recently become apparent (46) . Of the four 3ЈX binding proteins identified in this study, three have proposed extraribosomal functions. S3 has been reported to play a role in processing of DNA damage and DNA repair (67); L3 binds and stabilizes human immunodeficiency virus RNA sequences (51); and L22, in addition to binding small viral RNA molecules (63) , can also interact with human telomerase RNA (37) and poly(ADP-ribose) polymerase (in Drosophila melanogaster) (32) .
Indeed, it has been recently suggested that the abundance of L22 in the nucleolus or associated with ribosomes and EBERs (in EBV-positive cells) places the protein in a variety of multiprotein complexes, consistent with a possible role in RNA processing and RNP assembly (37) . The finding that HCV 3ЈX interacts with human L22, L3, S3, and mL3 adds HCV to the growing list of viruses that can interact with RPs. The significance of these interactions, however, may not be understood until efficient replication and packaging assays are developed or until the extraribosomal functions of the individual RPs within the cell are elucidated.
